|
Volumn 2, Issue 4, 1996, Pages 243-250
|
Soluble tumor necrosis factor (sTNF) receptors: A possible prognostic marker for bone marrow transplantation-related complications
a a a a a a a |
Author keywords
Bone marrow transplantation; Soluble tumor necrosis factor receptors
|
Indexed keywords
ALEMTUZUMAB;
BUSULFAN;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
MELPHALAN;
MITOXANTRONE;
THIOTEPA;
TUMOR NECROSIS FACTOR RECEPTOR;
ADOLESCENT;
ADULT;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
FEMALE;
GRAFT VERSUS HOST REACTION;
HUMAN;
INFECTION;
MALE;
POSTOPERATIVE COMPLICATION;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PROGNOSIS;
SCHOOL CHILD;
ADOLESCENT;
ADULT;
ANEMIA;
ANTIGENS, CD;
BIOLOGICAL MARKERS;
BONE MARROW TRANSPLANTATION;
BREAST NEOPLASMS;
CHILD;
FEMALE;
GRAFT VS HOST DISEASE;
HUMANS;
LEUKEMIA;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
MYELODYSPLASTIC SYNDROMES;
POSTOPERATIVE COMPLICATIONS;
PROGNOSIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;
RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;
RECURRENCE;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0030513205
PISSN: 13556568
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (23)
|
References (44)
|